FT : Germany’s Signa Sports agrees $3.2bn Spac deal for NY listing

Germany’s Signa Sports agrees $3.2bn Spac deal for NY listing
Online retailer acquires UK rival Wiggle as part of tie-up with Ron Burkle investment vehicle

Berlin-based online retailer Signa Sports United has struck a deal to list in New York through a merger with a blank cheque company led by US billionaire Ron Burkle, in a tie-up valuing the group at $3.2bn.

Signa, which offers customised services from selling high-end bikes and hiking gear to stringing tennis racquets, is seeking rapid expansion through acquiring smaller rivals in the US and Europe.

The move is a bet that the rise of online retailing can transform what had previously been seen as a niche market: serving the desires of enthusiastic amateurs obsessed by sports.

Signa Sports still faces a fierce battle for customers online, where the market is dominated by large US rivals such as Amazon and eBay, as well as established sports retailers such as Decathlon, which also continue to expand their offerings and services.

But Stephan Zoll, chief executive of Signa Sports, is confident that consumers will choose to buy their sports equipment from a specialist provider with a wider range of stock and the ability to customise products.

“We’re offering the user or the consumer much more than just a regular one size fits all shopping experience,” he said. “We string tennis rackets, we customise bikes, we customise team jersey sets. All of these value added services you don’t find in a general store.”

The former vice-president of eBay’s German business said Signa will continue to benefit as customers of specialist retailers shift to buying more over the internet.

As part of the deal, Signa Sports will also acquire UK-based online rival Wiggle from its private equity owners, the company said on Friday.

Signa Sports and Wiggle expect to generate a combined $1.6bn in net revenues in the current financial year to September.

Spacs have become a popular alternative to the traditional IPO process for companies looking to list on a stock exchange, accounting for nearly half of the more than $200bn raised globally in new listings over the past year.

The Spac structure will allow Signa to raise more capital than in a European initial public offering while also acquiring Wiggle, said Alex Johnstone, chief financial officer. He said the deal, which is expected to leave the company with $350m in cash on its balance sheet, will give it the firepower for more deals.

Yucaipa Acquisition Corp, a special purpose acquisition vehicle launched last year by Burkle, is contributing $345m in cash and an additional $300m through a so-called Pipe, or private investment in public equity. Burkle, the majority shareholder in private members’ club group Soho House, is also personally providing $50m to the Pipe alongside other investors.

Financial terms of the Wiggle deal were not released, but a person close to the company said Signa Sports is acquiring the retailer for $570m.

Signa Sports’ other brands include Fahrrad.de, Bikester, Probikeshop, Campz, Addnature, Outfitter and Stylefile. It also provides ecommerce technology to other companies, for example running the online shop for the International Tennis Federation, the governing body for tennis.

The deal with Burkle’s Yucaipa comes after Signa Sports acquired Ohio-based Midwest Sports in February, giving it a large presence in the US for the first time.

FT : Man Group’s CIO Sandy Rattray to leave hedge fund firm

Man Group’s CIO Sandy Rattray to leave hedge fund firm
Move triggers reshuffle of London-based group’s senior management

Man Group’s chief investment officer Sandy Rattray is to leave the group, sparking a reshuffle of the hedge fund firm’s senior management.

Rattray, a former Goldman Sachs staffer and a co-creator of the Vix index of market volatility, will hand over his responsibilities in the next few months and leave in the second half of the year, Man Group said. He has decided to leave the financial services industry to study architecture, according to people familiar with his plans.

Rattray has risen up the ranks at Man over the past decade. He became chief investment officer of systematic strategies in 2010, and then in 2013, as part of sweeping changes under new chief executive Manny Roman, became chief executive of its AHL unit, before advancing to CIO. Under Rattray’s stewardship, AHL’s assets have risen from $11.9bn at the end of 2013 to $45.3bn this year.

Man has endured mixed fortunes in recent years. It weathered the onset of the pandemic better than some rivals, posting a relatively small drop in assets and some net inflows in the first quarter of 2020, and posted inflows of $1.8bn for the calendar year. Assets have risen to a record $127bn this year.

However, investment performance has lagged behind in some areas, including its GLG European Long-Short fund and some computer-driven funds.

Man’s shares rose 0.4 per cent on Friday to 182p but are still below the 217p they hit in early 2018. In summer 2008, at their peak, they were worth more than 600p.

The $3.8tn hedge fund industry largely fared well during the worst of the market crisis last year. Funds on average gained 11.8 per cent, according to data group HFR, their best year of gains since 2009’s market rally in the wake of the global financial crisis. The industry’s best-performing managers enjoyed their biggest gains in a decade, according to LCH Investments.

However, some computer-driven managers have struggled with market volatility and to cope with its sharp reversals, with firms such as Bridgewater Associates and Renaissance Technologies enduring a tough year. Winton Group, set up by David Harding, a co-founder of Man’s AHL unit, has suffered a slump in assets after poor performance.

Following Rattray’s exit the role of CIO will be scrapped. However, chief financial officer Mark Jones will step down from the board to take on the role of deputy chief executive, looking after the AHL and Numeric units and Man’s technology functions that Rattray has led. Man also said that Antoine Forterre, who is co-chief executive of AHL, will become Man’s chief financial officer, succeeding Jones.

Man’s chair John Cryan said Rattray had played “a huge part in driving our innovation and growth”.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • CHWY -1%

Other news:

  • VRTX -13.7% (releases data from Phase 2 study of VX-864)
  • CRIS -12.8% (reports updated data from ongoing Phase 1/2 study of CA-4948 Monotherapy)
  • ELY -4.1% (to be added to S&P MidCap 400)
  • SNOW -3.5% (hosting Investor Day today)
  • INCY -3.1% (announces that the U.S. Food and Drug Administration has extended the review period for the New Drug Application for ruxolitinib cream for the treatment of atopic dermatitis)
  • AGNC -3% (reports tangible net book value of $16.82/sh)
  • ADC -3% (prices offering of 4 mln shares of common stock for gross proceeds of $286 mln)
  • LTHM -2.1% (prices offering of 13 mln shares of common stock at $17.50 per share)
  • REVG -1.6% (prices offering of 5.5 mln shares of common stock by selling shareholders at $15.50 per share)
  • EGLX -1.6% (priced 8 mln share offering at $5.75 per common share)

Analyst comments:

  • LOGI -1.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
  • CRCT -1.5% (downgraded to Equal-Weight from Overweight at Morgan Stanley)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • PLAY +5.5%, AVO +1.2%

Other news:

  • NOVN +39.4% (reports Phase 3 Trial of SB206 met primary endpoint)
  • PGEN +27.6% (announces "positive" top-line results from Phase 1b/2a study of AG019)
  • AMEH +10.8% (to be added to S&P SmallCap 600)
  • ATC +7.6% (MKS Instruments (MKSI) eyeing Atotech acquisition, according to Reuters)
  • EQ +7.4% (announces "positive" topline data from the Phase 1b EQUATE study in first-line acute graft-versus-host-disease)
  • RFP +7.2% (declares special dividend of $1/sh; also announces $50 mln in lumber investments)
  • ADMP +6.9% (reports clinical trial start-up activities are underway for examining the effects of Tempol in the treatment of COVID-19)
  • MBIO +6.3% (updates interim data from the ongoing Phase 1/2 clinical trial investigating the safety and efficacy of MB-106 CD20-targeted, autologous CAR T cell therapy)
  • CNTY +5.2% (reopening its four casinos in Alberta, Canada)
  • TYME +5% (completes strategic review, announces OASIS breast trial with Georgetown, reports earnings)
  • SRRK +4.9% (presents TOPAZ Phase 2 data showing the transformative potential of apitegromab in patients with Type 2 and 3 spinal muscular atrophy)
  • AUTL +4.2% (presents new data on obe-cel in r/r indolent B Cell lymphomas and gives an update of obe-cel in r/r Adult ALL)
  • VCTR +3.8% (reports May AUM)
  • LSCC +3.8% (Infineon is using LSCC FPGA as part of its Pictor design)
  • CVI +3.2% (finalizes special dividend payment)
  • EDIT +2.1% (reports preclinical data supporting the initiation of the EDIT-301 Phase 1/2 RUBY Clinical Trial for the treatment of sickle cell disease)
  • ABCL +2% (stock offering)
  • YAC +1.4% (SIGNA Sports United to go public on NYSE through combination with Yucaipa Acquisition Corporation)
  • IMRA +1.4% (Presents Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association)
  • BSN +1.3% (announces combination agreement with Vertical Aerospace; also Avolon confirms eVTOL aircraft order with Vertical Aerospace; also AAL confirms investment in Vertical Aerospace and aircraft pre-order agreement)
  • RWT +1.1% (increases dividend)

Analyst comments:

  • ERJ +4% (upgraded to Buy from Neutral at BofA Securities)
  • CELH +3.2% (upgraded to Outperform from Neutral at Credit Suisse)
  • BIIB +1% (upgraded to Outperform from Mkt Perform at Bernstein)

>>> US Early premarket gappers


Early premarket gappers

  • Gapping up:
    • PGEN +41.5%, AMEH +11.9%, RFP +7.8%, PLAY +5.6%, TYME +4.4%, VCTR +3.8%, LSCC +3.8%, CVI +3.5%, YAC +3.3%, BSN +2.8%, RWT +2.3%, EDIT +2.3%, CNTY +1.8%, IMRA +1.4%, AVO +1.2%, ABCL +0.7%, AAL +0.5%
  • Gapping down:
    • VRTX -12.8%, ELY -3.9%, SNOW -3.2%, ADC -3.2%, AGNC -1.9%, JFIN -1.1%, CHWY -0.6%, PBR -0.5%

>>> Europe : Brokers Upgrades & Downgrades - 11th of June 2021 V2(+)

>>> Up
* BioMerieux Raised to Buy at Stifel; PT 105 euros
* BioMerieux Raised to Hold at Berenberg; PT 95 euros
* DiaSorin Raised to Buy at Berenberg; PT 170 euros
* DSV Panalpina Raised to Buy at Handelsbanken; PT 1,625 kroner
* *H&M UPGR. TO EQUAL-WEIGHT VS UNDERWEIGHT IN MS ANALYST HANDOVER (+)
* HSBC Raised to Hold at Investec; PT 430 pence (+)
* *INDITEX RAISED TO EQUAL-WEIGHT VS UNDERWEIGHT AT MORGAN STANLEY (+)
* K+S Raised to Buy at Stifel; PT 15 euros
* Neinor Raised to Buy at JB Capital Markets; PT 15.60 euros (+)
* Raisio Cut to Hold at SEB Equities; PT 4 euros
* Raisio Cut to Hold at Nordea

>>> Down
* Ashtead Cut to Hold at Deutsche Bank; PT 5,018 pence
* Enagas Cut to Underperform at RBC; PT 16.50 euros
* Evonik Cut to Hold at SocGen; PT 30 euros
* Hapag-Lloyd Cut to Hold at Deutsche Bank; PT 180 euros
* Logitech Cut to Equal-Weight at Morgan Stanley
* MorphoSys Cut to Neutral at JPMorgan; PT 80 euros
* MorphoSys ADRs Cut to Neutral at JPMorgan; PT $24
* Nordic Semiconductor Cut to Neutral at SpareBank; PT 215 kroner
* Raisio Cut to Sell at Inderes; PT 3.60 euros (+)
* S Immo Cut to Accumulate at Erste Group; PT 26 euros

>>> Initiation
* Argan Rated New Overweight at Barclays; PT 117 euros
* Catena Rated New Equal-Weight at Barclays; PT 500 kronor
* CTP Rated New Overweight at Barclays; PT 20 euros
* Montea Rated New Equal-Weight at Barclays; PT 110 euros
* VGP NV Rated New Overweight at Barclays; PT 200 euros
* VIB Vermoegen Rated New Overweight at Barclays; PT 40 euros
* WDP Rated New Overweight at Barclays; PT 38.20 euros

>>> Call
* Ashtead Downgraded at Deutsche Bank on Valuation Grounds
* Berenberg Says Turning More Constructive on Diagnostics Stocks
* DSV Benefits From Strong Trading Conditions; SHB Upgrades to Buy
* Enagas Cut at RBC as Leftist Candidate Claims Win in Peru Vote
* Grifols Shares May Rise on Vertex Setback, MS Says (+)
* H&M Short-Term Outlook Promising, Visibility Low: Morgan Stanley (+)

>>> TradeGate Pre-Market Indications

DAX:
  • No major moves
MDAX:
  • K+S (SDF TH) +3.3%
    • K+S Raised to Buy at Stifel; PT 15 euros
  • Thyssenkrupp (TKA TH) +1.5%
  • Aixtron (AIXA TH) +1.1%
  • Evonik (EVK TH) -0.7%
    • Evonik Cut to Hold at SocGen; PT 30 euros
  • Fraport (FRA TH) -1.1%
    • Fraport Roadshow Scheduled By Bankhaus Metzler for June 11
  • MorphoSys (MOR TH) -1.2%
    • MorphoSys Cut to Neutral at JPMorgan; PT 80 euros
SDAX:
  • ADVA Optical (ADV TH) +1.9%
  • Salzgitter (SZG TH) +1%

>>> Stoxx 600 Pre-Market Indications

  • Carnival Plc (POH1 TH) +2.1%
    • Carnival PLC: Mardi Gras First Cruise Confirmed, More CCL Ships in Aug
  • Argenx (1AE TH) +1.9%
    • Stock up 11% so far this week
  • Rio Tinto (RIO1 TH) +1.9%
  • Glaxo (GS7 TH) +1.2%
  • Polymetal (PM6 TH) +1%
  • Grifols (OZTA TH) +1%
  • Evonik (EVK TH) -0.7%
    • Evonik Cut to Hold at SocGen; PT 30 euros
  • Shell (R6C TH) -0.7%
  • Fresenius Medical (FME TH) -0.8%
  • Fresenius SE (FRE TH) -0.8%
  • Randstad (RSH TH) -1.1%
  • Essity (ESWB TH) -1.1%
  • MorphoSys (MOR TH) -1.3%
    • MorphoSys Cut to Neutral at JPMorgan; PT 80 euros

>>> Europe : Brokers Upgrades & Downgrades - 11th of June 2021

>>> Up
* BioMerieux Raised to Buy at Stifel; PT 105 euros
* BioMerieux Raised to Hold at Berenberg; PT 95 euros
* DiaSorin Raised to Buy at Berenberg; PT 170 euros
* DSV Panalpina Raised to Buy at Handelsbanken; PT 1,625 kroner
* K+S Raised to Buy at Stifel; PT 15 euros
* Raisio Cut to Hold at SEB Equities; PT 4 euros
* Raisio Cut to Hold at Nordea

>>> Down
* Ashtead Cut to Hold at Deutsche Bank; PT 5,018 pence
* Enagas Cut to Underperform at RBC; PT 16.50 euros
* Evonik Cut to Hold at SocGen; PT 30 euros
* Hapag-Lloyd Cut to Hold at Deutsche Bank; PT 180 euros
* Logitech Cut to Equal-Weight at Morgan Stanley
* MorphoSys Cut to Neutral at JPMorgan; PT 80 euros
* MorphoSys ADRs Cut to Neutral at JPMorgan; PT $24
* Nordic Semiconductor Cut to Neutral at SpareBank; PT 215 kroner
* S Immo Cut to Accumulate at Erste Group; PT 26 euros

>>> Initiation
* Argan Rated New Overweight at Barclays; PT 117 euros
* Catena Rated New Equal-Weight at Barclays; PT 500 kronor
* CTP Rated New Overweight at Barclays; PT 20 euros
* Montea Rated New Equal-Weight at Barclays; PT 110 euros
* VGP NV Rated New Overweight at Barclays; PT 200 euros
* VIB Vermoegen Rated New Overweight at Barclays; PT 40 euros
* WDP Rated New Overweight at Barclays; PT 38.20 euros

>>> Call
* Ashtead Downgraded at Deutsche Bank on Valuation Grounds
* Berenberg Says Turning More Constructive on Diagnostics Stocks
* DSV Benefits From Strong Trading Conditions; SHB Upgrades to Buy
* Enagas Cut at RBC as Leftist Candidate Claims Win in Peru Vote